Gongqin Sun

1.8k total citations
77 papers, 1.4k citations indexed

About

Gongqin Sun is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gongqin Sun has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 25 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gongqin Sun's work include Protein Kinase Regulation and GTPase Signaling (32 papers), Melanoma and MAPK Pathways (17 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Gongqin Sun is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (32 papers), Melanoma and MAPK Pathways (17 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Gongqin Sun collaborates with scholars based in United States, China and India. Gongqin Sun's co-authors include Raymond J.A. Budde, Keykavous Parang, David J. Kemble, Xiaofeng Lin, Sungsoo Lee, Nguyen‐Hai Nam, Marina K. Ayrapetov, Guofeng Ye, Ajay Sharma and John Markwell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Gongqin Sun

76 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gongqin Sun United States 24 1.1k 273 188 166 142 77 1.4k
Richard A. Norman United Kingdom 18 1.0k 1.0× 269 1.0× 325 1.7× 141 0.8× 76 0.5× 26 1.5k
Yan Ling United States 23 1.0k 1.0× 230 0.8× 251 1.3× 81 0.5× 183 1.3× 60 1.8k
Wang‐Qing Liu France 20 805 0.8× 283 1.0× 194 1.0× 116 0.7× 124 0.9× 54 1.2k
Zoltán Greff Hungary 13 1.0k 1.0× 312 1.1× 225 1.2× 82 0.5× 86 0.6× 21 1.5k
Bainan Wu United States 22 880 0.8× 244 0.9× 150 0.8× 84 0.5× 103 0.7× 28 1.2k
Rob Ruijtenbeek Netherlands 21 854 0.8× 219 0.8× 215 1.1× 206 1.2× 151 1.1× 64 1.2k
Scott Jakes United States 23 1.0k 1.0× 267 1.0× 202 1.1× 186 1.1× 327 2.3× 29 1.6k
Jeremy Murray United States 22 1.4k 1.3× 311 1.1× 204 1.1× 92 0.6× 136 1.0× 36 1.8k
Jeffrey H. Till United States 11 1.3k 1.2× 431 1.6× 166 0.9× 215 1.3× 173 1.2× 12 1.9k
Melissa Millard United States 14 1.1k 1.1× 298 1.1× 172 0.9× 73 0.4× 151 1.1× 18 1.9k

Countries citing papers authored by Gongqin Sun

Since Specialization
Citations

This map shows the geographic impact of Gongqin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gongqin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gongqin Sun more than expected).

Fields of papers citing papers by Gongqin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gongqin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gongqin Sun. The network helps show where Gongqin Sun may publish in the future.

Co-authorship network of co-authors of Gongqin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Gongqin Sun. A scholar is included among the top collaborators of Gongqin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gongqin Sun. Gongqin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Gongqin, et al.. (2024). Molecular Pharmacology of Dasatinib Provides Unique Insights into the Mechanistic Basis of Success and Failure of Targeted Cancer Therapy. ACS Pharmacology & Translational Science. 8(1). 1–9. 1 indexed citations
2.
3.
Chen, Junjun, Jie Dai, Ting Yang, et al.. (2020). A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer. Experimental Cell Research. 393(1). 112060–112060. 7 indexed citations
4.
5.
Wang, Xi, Wei Yan, Qi Zhang, et al.. (2019). ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma. Cancer Gene Therapy. 27(10-11). 754–767. 11 indexed citations
6.
7.
Kumar, Anil, et al.. (2007). Synthesis and Evaluation of 3‐Phenylpyrazolo[3,4‐d]pyrimidine‐Peptide Conjugates as Src Kinase Inhibitors. ChemMedChem. 2(9). 1346–1360. 23 indexed citations
8.
Ahmadibeni, Yousef, Michael R. Hanley, Marina K. Ayrapetov, et al.. (2007). Metal‐Binding Properties of a Dicysteine‐Containing Motif in Protein Tyrosine Kinases. ChemBioChem. 8(13). 1592–1605. 5 indexed citations
9.
Ayrapetov, Marina K., et al.. (2006). A new strategy to produce active human Src from bacteria for biochemical study of its regulation. Biochemical and Biophysical Research Communications. 346(2). 606–611. 17 indexed citations
10.
Ayrapetov, Marina K., et al.. (2006). Conformational Basis for SH2-Tyr(P)527 Binding in Src Inactivation. Journal of Biological Chemistry. 281(33). 23776–23784. 23 indexed citations
11.
Parang, Keykavous & Gongqin Sun. (2005). Recent advances in the discovery of Src kinase inhibitors. Expert Opinion on Therapeutic Patents. 15(9). 1183–1207. 21 indexed citations
12.
Ye, Guofeng, Marina K. Ayrapetov, Nguyen‐Hai Nam, Gongqin Sun, & Keykavous Parang. (2005). Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 15(22). 4994–4997. 2 indexed citations
13.
Nam, Nguyen‐Hai, Rebecca Pitts, Gongqin Sun, et al.. (2004). Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorganic & Medicinal Chemistry. 12(4). 779–787. 27 indexed citations
14.
Nam, Nguyen‐Hai, Sungsoo Lee, Guofeng Ye, Gongqin Sun, & Keykavous Parang. (2004). ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases. Bioorganic & Medicinal Chemistry. 12(22). 5753–5766. 23 indexed citations
15.
Ayrapetov, Marina K., Sungsoo Lee, & Gongqin Sun. (2003). Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase. Protein Expression and Purification. 29(2). 148–155. 12 indexed citations
16.
Sun, Gongqin & Raymond J.A. Budde. (1999). Mutations in the N-Terminal Regulatory Region Reduce the Catalytic Activity of Csk, but Do Not Affect Its Recognition of Src. Archives of Biochemistry and Biophysics. 367(2). 167–172. 25 indexed citations
17.
Ramdas, Latha, Matthew J. Plunkett, Gongqin Sun, et al.. (1999). Benzodiazepine Compounds as Inhibitors of the Src Protein Tyrosine Kinase: Screening of a Combinatorial Library of 1,4-Benzodiazepines. Archives of Biochemistry and Biophysics. 368(2). 394–400. 16 indexed citations
18.
Sun, Gongqin, Ajay Sharma, & Raymond J.A. Budde. (1998). Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation. Oncogene. 17(12). 1587–1595. 79 indexed citations
19.
Sun, Gongqin & Raymond J.A. Budde. (1995). A Modified pGEX Expression System That Eliminates Degradation Products and Thrombin from the Recombinant Protein. Analytical Biochemistry. 231(2). 458–460. 21 indexed citations
20.
Sun, Gongqin, Dana Bailey, Michael W. Jones, & John Markwell. (1989). Chloroplast Thylakoid Protein Phosphatase Is a Membrane Surface-Associated Activity. PLANT PHYSIOLOGY. 89(1). 238–243. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard A. Norman Breakdown of academic impact, for papers by Yan Ling Breakdown of academic impact, for papers by Wang‐Qing Liu Breakdown of academic impact, for papers by Zoltán Greff Breakdown of academic impact, for papers by Bainan Wu Breakdown of academic impact, for papers by Rob Ruijtenbeek Breakdown of academic impact, for papers by Scott Jakes Breakdown of academic impact, for papers by Jeremy Murray Breakdown of academic impact, for papers by Jeffrey H. Till Breakdown of academic impact, for papers by Melissa Millard
Rankless by CCL
2026